Abstract
Objective
The purpose of this study is to investigate the effect of Shenfu injection (SFI) on the tumor necrosis factor-α (TNF-α) and the interleukin (IL-6, IL-8, IL-10) of elderly patients who suffered from severe pneumonia.
Methods
From June 2012 to September 2014, we performed in our department 89 cases of elderly patients with severe pneumonia. These patients were randomly divided into two groups: the treatment group (45 cases) and the control group (44 cases). The control group was given the treatment of anti-infection, reducing sputum, and support therapy, while the treatment group was fed by SFI intravenously based on the control group. The TNF-α and the interleukin were detected by enzyme-linked immunosorbent assay (ELISA). Meanwhile, the changes in the inflammatory response indicators, the blood gas analysis, and the parameters of vital signs were measured and compared before and after therapy.
Results
Prior to treatment, there is no significant difference between the treatment group and the control group (p > 0.05); after the treatment for 7 days, the levels of TNF-α, IL-6, and IL-8 were significantly decreased, while the level of IL-10 was obviously increased. The APACHE II score was significantly decreased in comparison to that before the treatment (p < 0.05), and the time of mechanical ventilation, the duration of time in ICU, and the application time of vasoactive drugs were notably shortened.
Conclusion
The application of Shenfu injection exhibited a positive and effective effect on removing the inflammation media during the treatment of elderly severe pneumonia.
Similar content being viewed by others
References
El-Solh AA, Sikka P, Ramadan F, Davies J. Etiology of severe pneumonia in the very elderly. Am J Respir Crit Care Med. 2001;163:645–51.
Pinner RW, Teutsch SM, Simonsen L, Klug LA, Graber JM, Clarke MJ, Berkelman RL. Trends in infectious diseases mortality in the United States. JAMA. 1996;275:189–93.
Almirall J, Mesalles E, Klamburg J, Parra O, Agudo A. Prognostic factors of pneumonia requiring admission to the intensive care unit. Chest. 1995;107:511–6.
Günther A, Mosavi P, Heinemann S, Ruppert C, Muth H, Markart P, Grimminger F, Walmrath D, Temmesfeld-Wollbrück B, Seeger W. Alveolar fibrin formation caused by enhanced procoagulant and depressed fibrinolytic capacities in severe pneumonia. Am J Respir Crit Care Med. 2000;161:454–62.
Bauer TT, Montón C, Torres A, Cabello H, Fillela X, Maldonado A, Nicolás JM, Zavala E. Comparison of systemic cytokine levels in patients with acute respiratory distress syndrome, severe pneumonia, and controls. Thorax. 2000;55:46–52.
Zhang Q, Li CS, Wang S, Gu W. Effects of Chinese medicine Shen-Fu injection on the expression of inflammatory cytokines and complements during post-resuscitation immune dysfunction in A porcine model. Chin J Integr Med. 2016;22:101–9.
Wang J, Qiao LF, Yang GT. Role of Shenfu injection in rats with systemic inflammatory response syndrome. Chin J Integr Med. 2008;14:51–5.
Mandell LA, Wunderink RG, Anzueto A, Bartlett JG, Campbell GD, Dean NC, Dowell SF, File TM, Musher DM, Niederman MS, Torres A, Whitney CG. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007;44:27–72.
Guo KP, Liu YN, Li K. Adult severe community acquired pneumonia of inflammatory factors in blood serum and its clinical significance. Guide China Med. 2012;10:420–2.
Tang ZX, Zeng M, Lu GF. Changes of plasma levels of soluble triggering receptor expressed on myeloid cell-1, tumor necrosis factor-α and interleukin-10 in severe pneumonia. Chin J Respir Crit Care Med. 2011;10:424–8.
Sun L, Comell TT, Le Vine A, Berlin AA, Hinkovska-Galcheva V, Fleszar AJ, Lukacs NW, Shanley TP. Dual role of interleukin-10 in the regulation of respiratory syncitial virus (RSV)-induced lung inflammation. Clin Exp Immunol. 2013;172:263–79.
Hou XM, Li CS, Gu W, Guo ZJ, Yin WP, Zhang D. Effect of Shenfu on inflammatory cytokine release and brain edema after prolonged cardiac arrest in the swine. Am J Emerg Med. 2013;31:1159–64.
Lin H, Ma C, Wang R, Liang D. Effect of Shenfu injection on blood lactate and prognosis in patients with severe pneumonia. J Emerg Tradit Chin Med. 2013;22:199–200.
Li P. Hemodynamic effects of severe pneumonia by Shenfu injection. Guide China Med. 2012;10:52–3.
Li G, Zhao JF, Wang KC, Chen HP. Impact of Shenfu injection on neuroendocrine-immune network in experimental septic rats. Chin J Surg Integr Tradit West Med. 2011;17:185–9.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
The authors state that the effect that all human and animal studies have been approved by the appropriate ethics committee and have, therefore, been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.
Conflict of interest
Shi-Jin Lv, Deng-Pan Lai, Xia Wei, Qian Yan, and Jin-Ming Xia declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Lv, S.J., Lai, D.P., Wei, X. et al. The protective effect of Shenfu injection against elderly severe pneumonia. Eur J Trauma Emerg Surg 43, 711–715 (2017). https://doi.org/10.1007/s00068-016-0713-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00068-016-0713-2